Selective anticancer effects and protection from chemotherapy by the botanical compound LCS101: Implications for cancer treatment

International Journal of Oncology

Volumn 46, Issue 1, 2015, Pages 308-316

  Cohen, Zoya ^a   Maimon, Yair ^a   Yoeli Lerner, Merav ^a   Yang, Peiying ^b   Samuels, Noah ^a   Berger, Raanan ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Botanical compounds; Cancer; Chemotherapy; Cytotoxicity; Necrosis; PARP 1; Protective

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; HERBACEOUS AGENT; LCS101; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, HUMAN; PLANT EXTRACT;

APOPTOSIS; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; DRUG EFFECTS; GENETICS; HCT116 CELL LINE; HUMAN; MCF 7 CELL LINE; METABOLISM; NEOPLASMS; PHYTOTHERAPY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL DEATH; CELL PROLIFERATION; CELLS, CULTURED; CYTOPROTECTION; DOXORUBICIN; DRUGS, CHINESE HERBAL; HCT116 CELLS; HUMANS; MCF-7 CELLS; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; POLY(ADP-RIBOSE) POLYMERASES;

EID: 84917706606     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2711     Document Type: Article

References (21)

1. World Health Organization fact sheet No. 297; http://www. who.int/mediacentre/factsheets/fs297/en/index.html. Accessed December 28, 2013.
2. Liu SH and Cheng YC: Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. J Ethnopharmacol 140: 614-623, 2012.
3. Samuels N, Maimon Y and Zisk-Rony RY: Effect of the botanical compound LCS101 on chemotherapy-induced symptoms in patients with breast cancer: a case series report. Integr Med Insights 8: 1-8, 2013.
4. Maimon Y, Karaush V, Yaal-Hahoshen N, Ben-Yosef R, Ron I, Vexler A and Lev-Ari S: Effect of Chinese herbal therapy on breast cancer adenocarcinoma cell lines. J Int Med Res 38: 2033-2039, 2010.
5. Rachmut IH, Samuels N, Melnick SJ, Ramachandran C, Sharabi Y, Pavlovsky A, Maimon Y and Shoham J: Immunomodulatory effects of the botanical compound LCS101: implications for cancer treatment. Onco Targets Ther 6: 437-445, 2013.
6. Yaal-Hahoshen N, Maimon Y, Siegelmann-Danieli N, Lev-Ari S, Ron IG, Sperber F, Samuels N, Shoham J and Merimsky O: A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer. Oncologist 16: 1197-1202, 2011.
7. Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, Cohen Y, Jacob-Hirsch J, Ehrlich M, Ben-Sasson S, Goldfinger N, Loewenthal R, Gazit E, Rotter V and Berger R: TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model. PLoS One 6: e21650, 2011.
8. Butters DJ, Ghersi D, Wilcken N, Kirk SJ and Mallon PT: Addition of drug/s to a chemotherapy regimen for metastatic breast cancer. Cochrane Database Syst Rev 2010: CD003368. doi: 10.1002/14651858.CD003368.pub3.
9. Sun JY, Yang H, Miao S, Li JP, Wang SW, Zhu MZ, Xie YH, Wang JB, Liu Z and Yang Q: Suppressive effects of swainsonine on C6 glioma cell in vitro and in vivo. Phytomedicine 16: 1070-1074, 2009.
10. Huang HL, Chen CC, Yeh CY and Huang RL: Reactive oxygen species mediation of baizhu-induced apoptosis in human leukemia cells. J Ethnopharmacol 97: 21-29, 2005.
11. Kang SA, Park HJ, Kim MJ, Lee SY, Han SW and Leem KH: Citri Reticulatae Viride Pericarpium extract induced apoptosis in SNU-C4, human colon cancer cells. J Ethnopharmacol 97: 231-235, 2005.
12. Kim MJ, Park HJ, Hong MS, Park HJ, Kim MS, Leem KH, Kim JB, Kim YJ and Kim HK: Citrus Reticulata blanco induces apoptosis in human gastric cancer cells SNU-668. Nutr Cancer 51: 78-82, 2005.
13. Jeong JC, Kim JW, Kwon CH, Kim TH and Kim YK: Fructus ligustri lucidi extracts induce human glioma cell death through regulation of Akt/mTOR pathway in vitro and reduce glioma tumor growth in U87MG xenograft mouse model. Phytother Res 25: 429-434, 2011.
14. Wong BY, Lau BH, Jia TY and Wan CP: Oldenlandia diffusa and Scutellaria barbata augment macrophage oxidative burst and inhibit tumor growth. Cancer Biother Radiopharm 11: 51-56, 1996.
15. Gupta S, Zhang D, Yi J and Shao J: Anticancer activities of Oldenlandia diffusa. J Herb Pharmacother 4: 21-33, 2004.
16. Ou TT, Wu CH, Hsu JD, Chyau CC, Lee HJ and Wang CJ: Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in vivo. J Ethnopharmacol 135: 162-172, 2011.
17. Feng L, Jia X, Zhu M, Chen Y and Shi F: Chemoprevention by Prunella vulgaris L. extract of non-small cell lung cancer via promoting apoptosis and regulating the cell cycle. Asian Pac J Cancer Prev 11: 1355-1358, 2010.
18. Choi JH, Han EH, Hwang YP, Choi JM, Choi CY, Chung YC, Seo JK and Jeong HG: Suppression of PMA-induced tumor cell invasion and metastasis by aqueous extract isolated from Prunella vulgaris via the inhibition of NF-kappaB-dependent MMP-9 expression. Food Chem Toxicol 48: 564-571, 2010.
19. Klawitter J, Klawitter J, Gurshtein J, Corby K, Fong S, Tagliaferri M, Quattrochi L, Cohen I, Shtivelman E and Christians U: Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: a combined proteomic and metabolomic study. Int J Cancer 129: 2945-2957, 2011.
20. Fong S, Shoemaker M, Cadaoas J, Lo A, Liao W, Tagliaferri M, Cohen I and Shtivelman E: Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells. Cancer Biol Ther 7: 577-586, 2008.
21. Wong BY, Nguyen DL, Lin T, Wong HH, Cavalcante A, Greenberg NM, Hausted RP and Zheng J: Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice. Eur J Cancer Prev 18: 331-341, 2009.